A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study the efficacy, safety and tolerability of idebenone in
12 months of treatment in children and adults with Friedreich's Ataxia. This is a randomised
placebo-controlled double-blind trial conducted in Europe. Efficacy outcomes include measures
of neurological impairment and function, and measures of the heart.